Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma
Clin. Cancer Res 2022 Sep 08;[EPub Ahead of Print], R Termini, D Zihala, E Terpos, A Pérez-Montaña, T Jelinek, M Raab, N Weinhold, EK Mai, AL Grab, J Corre, F Vergez, A Sacco, M Chiarini, V Giustini, A Tucci, S Rodríguez, C Moreno, C Perez, C Maia, E Martin-Sanchez, C Guerrero, C Botta, JJ Garcés, A Lopez, LE Tamariz-Amador, F Prósper, J Bargay, ME Cabezudo, EM Ocio, R Hájek, J Martinez-Lopez, F Solano, R Iglesias, A Paiva, C Geraldes, H Matos Silva, C Gomez, F De Arriba, H Ludwig, A Garcia-Guiñon, M Casanova, A Alegre, V Cabañas, M Sirvent, A Oriol, J De la Rubia, JÁ Hernández-Rivas, L Palomera, M Sarasa, P Rios, N Puig, MV Mateos, J Flores-Montero, A Orfao, H Goldschmidt, H Avet-Loiseau, AM Roccaro, JF San-Miguel, B PaivaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.